We present the case of a 70-year-old woman with coralliform mitral annular calcification (MAC) and porcelain aorta with multimodality approach of the mitral disease as shown in Figure 1. The heart team considered inoperable because of high risk of perioperative atrioventricular groove disruption or frank rupture with massive bleeding because of the coralliform MAC and porcelain aorta and consequently death and considered only medical treatment (Society of Thoracic Surgeons of 6.15% and EuroSCORE II of 6.61%). The patient develops nodal rhythm and electrophysiologist decided to install dual-chamber permanent pacemakers. At a 6-month follow-up visit, with optimal medical treatment, she had only mild dyspnea (New York Heart Association Class II). The mitral valve disease is an extreme form of MAC, with extension of calcification into the leaflets and subvalvular apparatus like this case. The association of MAC and porcelain aorta represents great difficulty for surgical treatment because of unsafe aortic cross-clamping or arterial cannulation1. Actually, the therapeutic options are multiple in patients with MAC; the Mount Sinai algorithm starts with surgical risk assessment and then anatomical analysis and includes surgical treatment (replace or surgical mitral valve repair), percutaneous or hybrid, and medical treatment in inoperable cases, like our patient2.
Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Similares en SciELO
Compartir
Archivos de cardiología de México
versión On-line ISSN 1665-1731versión impresa ISSN 1405-9940
Arch. Cardiol. Méx. vol.91 no.2 Ciudad de México abr./jun. 2021 Epub 14-Mayo-2021
https://doi.org/10.24875/acm.20000188
Imágenes en cardiología
Left heart side calcification: coralliform mitral annular calcification and porcelain aorta
Calcificación del corazón izquierdo: anillo mitral coraliforme y aorta en porcelana
1Department of Valvular Heart Disease
2Department of Computed Tomography
3Department of Echocardiography
4Department of Electrophysiology
5Department of Pulmonary Hypertension Clinic and Right Ventricle. Hospital de Cardiología, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico
References
1. Shamsudeen I, Fei LY, Burwash IG, Beauchesne L, Chan V, Glineur D, et al. Presentation and management of calcific mitral valve disease. Int J Cardiol. 2020;304:135-7. [ Links ]
2. El-Eshmawi A, Alexis SL, Sengupta A, Pandis D, Rimsukcharoenchai C, Adams DH, et al. Surgical management of mitral annular calcification. Curr Opin Cardiol. 2020;35:107-15. [ Links ]
Ethical disclosures
Protection of human and animal subjects. The authors declare that no experiments were performed on humans or animals for this study.
Confidentiality of data. The authors declare that they have followed the protocols of their work center on the publication of patient data.
Right to privacy and informed consent. The authors have obtained the written informed consent of the patients or subjects mentioned in the article. The corresponding author is in possession of this document.
Received: April 29, 2020; Accepted: May 27, 2020